Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2021 | Role of RT in early breast cancer

Icro Meattini • 8 Sep 2021
ESMO 2021
Breast Cancer
FLORENCE

Icro Meattini, MD, of University of Florence, Florence, Italy, highlights recent findings that have furthered our understanding of the radiotherapy in the treatment of patients with breast cancer, as well as current and future practices. This interview took place during the European Society for Medical Oncology (ESMO) 2021 congress.

More from Icro Meattini

2:11
Partial and no radiation in elderly patients with breast cancer
Icro Meattini • 21 Mar 2024
0:40
Innovations in radiation therapy planning
Icro Meattini • 6 Dec 2023
0:40
Innovations in radiation therapy planning
Icro Meattini • 6 Dec 2023
0:50
Patient-friendly radiation courses in breast cancer
Icro Meattini • 6 Dec 2023

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals